Global Third-Party Clinical Laboratory Market Growth (Status and Outlook) 2023-2029
The global Third-Party Clinical Laboratory market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Third-Party Clinical Laboratory is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Third-Party Clinical Laboratory is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Third-Party Clinical Laboratory is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Third-Party Clinical Laboratory players cover QUEST, LABCORP, Adicon, Kindstar Globalgene, Siemens AG, Sonic Healthcare Limited, Dian Diagnostics Group, Medicalsystem Biotechnology and BGI Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Third-Party Clinical Laboratory is an independent laboratory that provides testing services for medical and healthcare providers. These laboratories are not directly affiliated with a hospital or clinic, but rather operate as separate entities.
LPI (LP Information)' newest research report, the “Third-Party Clinical Laboratory Industry Forecast” looks at past sales and reviews total world Third-Party Clinical Laboratory sales in 2022, providing a comprehensive analysis by region and market sector of projected Third-Party Clinical Laboratory sales for 2023 through 2029. With Third-Party Clinical Laboratory sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Third-Party Clinical Laboratory industry.
This Insight Report provides a comprehensive analysis of the global Third-Party Clinical Laboratory landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Third-Party Clinical Laboratory portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Third-Party Clinical Laboratory market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Third-Party Clinical Laboratory and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Third-Party Clinical Laboratory.
This report presents a comprehensive overview, market shares, and growth opportunities of Third-Party Clinical Laboratory market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Large-Scale General Inspection Laboratory
Specialized Special Inspection Laboratory
Segmentation by application
Hospitals
Health Care Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QUEST
LABCORP
Adicon
Kindstar Globalgene
Siemens AG
Sonic Healthcare Limited
Dian Diagnostics Group
Medicalsystem Biotechnology
BGI Genomics
Hybribio Biotech
Daan Gene
Kingmed Diagnostics Group
Please note: The report will take approximately 2 business days to prepare and deliver.